Fda Approved Drug
- All
- News
- Videos
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
What Is 'Gas Station Heroin'? US Alarmed Over Surge In Its Use And Health Risks
Last month, the FDA issued a formal warning, calling tianeptine a dangerous and growing health trend".
-
FDA Approves 3 Food Colours - And They Are All Natural
This shift comes as part of U.S. health officials' broader health initiative, which includes the "Make America Healthy Again" campaign.
-
Could Dogs Live Longer? Breakthrough Pill Receives Key Regulator Approval
FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
Apple Receives US FDA Approval to Enable AirPods Pro 2 Hearing Aids Feature
AirPods Pro (2nd Generation) users will be able to use the company's truly wireless stereo (TWS) headset as a hearing aid in the future, as Apple has now received approval from the US Food and Drug Administration (FDA) to enable the feature. An update will also bring support for a new hearing test, which will generate an audio profile for the heari...
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
US Approves First Drug For People With Severe Form Of Fatty Liver Disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
What Is 'Gas Station Heroin'? US Alarmed Over Surge In Its Use And Health Risks
Last month, the FDA issued a formal warning, calling tianeptine a dangerous and growing health trend".
-
FDA Approves 3 Food Colours - And They Are All Natural
This shift comes as part of U.S. health officials' broader health initiative, which includes the "Make America Healthy Again" campaign.
-
Could Dogs Live Longer? Breakthrough Pill Receives Key Regulator Approval
FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
Apple Receives US FDA Approval to Enable AirPods Pro 2 Hearing Aids Feature
AirPods Pro (2nd Generation) users will be able to use the company's truly wireless stereo (TWS) headset as a hearing aid in the future, as Apple has now received approval from the US Food and Drug Administration (FDA) to enable the feature. An update will also bring support for a new hearing test, which will generate an audio profile for the heari...
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
US Approves First Drug For People With Severe Form Of Fatty Liver Disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
